iShares MSCI China ETF
MCHIDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 18, 2026 | $0.36 | 2026-06-15 | 2026-06-15 |
| December 19, 2025 | $0.74 | 2025-12-16 | 2025-12-16 |
| June 20, 2025 | $0.54 | 2025-06-16 | 2025-06-16 |
| December 20, 2024 | $0.89 | 2024-12-17 | 2024-12-17 |
| June 17, 2024 | $0.19 | 2024-06-11 | 2024-06-11 |
Dividends Summary
- Consistent Payer: iShares MSCI China ETF has rewarded shareholders with 33 dividend payments over the past 15 years.
- Total Returned Value: Investors who held MCHI shares during this period received a total of $15.89 per share in dividend income.
- Latest Payout: The most recent dividend of $0.36/share was paid 30 days ago, on June 18, 2026.
- Dividend Growth: Since 2011, the dividend payout has decreased by 62.1%, from $0.95 to $0.36.
Company News
China's Producer Price Index rose 0.5% year-over-year in March 2026, marking its first expansion since September 2022. However, China-focused ETFs remain cautious as the inflation is driven by rising input costs rather than demand, raising concerns about margin sustainability. ETF investors are taking a wait-and-see approach until a demand-led re...
Nipun Capital increased its position in iShares MSCI China ETF (MCHI) by 116,100 shares worth $7.3 million in Q4 2025, bringing its stake to 22.96% of AUM. While the purchase signals a bullish outlook on Chinese equities, the article cautions that MCHI carries heightened risk due to China-specific geopolitical tensions and a relatively high 0.59%...
Hong Kong-based Fosun International completely exited its $5.84 million position in the iShares MSCI China ETF (MCHI) during Q3, selling 106,000 shares. The exit comes after the ETF surged nearly 30% year-to-date, reflecting a broad recovery in Chinese equities. The move reflects risk management and portfolio rebalancing rather than bearish senti...
Investment firm SYON Capital increased its stake in the iShares MSCI China ETF by acquiring 132,464 shares in Q3 2025, bringing its total holding to 408,341 shares valued at $26.9 million, representing a cautiously optimistic approach to Chinese market investments.
Tian Ruixiang Holdings (TIRX) is acquiring Ucare, an AI-powered health platform, in a $150 million all-share deal. The acquisition aims to enhance TIRX's role in China's fast-growing health insurance sector by leveraging Ucare's AI platform and data.
